Earnings Feed
Start Free
Home/Insiders/RICKS THOMAS G
RT
SEC Insider//CIK 0001013023

RICKS THOMAS G

CIK 00010130234 companiesHOUSTON, TX
SEC Profile

Transactions

50

Companies

4

Filings

12

CIK

0001013023

Recent Transactions

50 trades
  • Gift
    Ovintiv Inc.$OVV

    Common Stock

    2025-12-05−900→ 95,369 total
  • Award
    Sensei Biotherapeutics, Inc.$SNSE

    Stock Option (Right to Buy)

    2025-05-21+19,000→ 19,000 total
  • Exercise/Conversion
    Ovintiv Inc.$OVV

    Restricted Share Unit

    2025-05-16−5,501→ 0 total
  • Award
    Ovintiv Inc.$OVV

    Restricted Share Unit

    2025-05-16+5,501→ 5,501 total
  • Exercise/Conversion
    Ovintiv Inc.$OVV

    Common Stock

    2025-05-16+5,501→ 100,332 total
  • Award
    Sensei Biotherapeutics, Inc.$SNSE

    Stock Option (Right to Buy)

    2024-06-11+19,000→ 19,000 total
  • Award
    Ovintiv Inc.$OVV

    Restricted Share Unit

    2024-05-17+4,213→ 4,213 total
  • Exercise/Conversion
    Ovintiv Inc.$OVV

    Common Stock

    2024-05-17+4,213→ 94,831 total
  • Exercise/Conversion
    Ovintiv Inc.$OVV

    Restricted Share Unit

    2024-05-17−4,213→ 0 total
  • Exercise/Conversion
    Ovintiv Inc.$OVV

    Common Stock

    2024-03-08+8,402→ 90,618 total
  • Exercise/Conversion
    Ovintiv Inc.$OVV

    Restricted Share Unit

    2024-03-08−8,402→ 0 total
  • Award
    Ovintiv Inc.$OVV

    Restricted Share Unit

    2023-12-29+57→ 8,402 total
  • Award
    Ovintiv Inc.$OVV

    Restricted Share Unit

    2023-09-29+50→ 8,345 total
  • Award
    Sensei Biotherapeutics, Inc.$SNSE

    Common Stock

    2023-07-10+4,466→ 8,932 total
  • Award
    Sensei Biotherapeutics, Inc.$SNSE

    Stock Option (Right to Buy)

    2023-07-10+14,550→ 14,550 total
  • Award
    Ovintiv Inc.$OVV

    Restricted Share Unit

    2023-06-30+65→ 8,295 total
  • Award
    Ovintiv Inc.$OVV

    Restricted Share Unit

    2023-05-18+6,074→ 14,304 total
  • Exercise/Conversion
    Ovintiv Inc.$OVV

    Common Stock

    2023-05-18+6,074→ 82,216 total
  • Exercise/Conversion
    Ovintiv Inc.$OVV

    Restricted Share Unit

    2023-05-18−6,074→ 8,230 total
  • Award
    Ovintiv Inc.$OVV

    Restricted Share Unit

    2023-03-31+58→ 8,230 total
  • Exercise/Conversion
    Ovintiv Inc.$OVV

    Restricted Share Unit

    2023-03-08−14,709→ 8,172 total
  • Exercise/Conversion
    Ovintiv Inc.$OVV

    Common Stock

    2023-03-08+14,709→ 76,142 total
  • Award
    Ovintiv Inc.$OVV

    Restricted Share Unit

    2022-12-30+113→ 22,881 total
  • Gift
    Ovintiv Inc.$OVV

    Common Stock

    2022-10-12−10,000→ 106,269 total
  • Gift
    Ovintiv Inc.$OVV

    Common Stock

    2022-10-12−10,000→ 96,269 total
  • Award
    Ovintiv Inc.$OVV

    Restricted Share Unit

    2022-09-30+124→ 22,768 total
  • Award
    Ovintiv Inc.$OVV

    Restricted Share Unit

    2022-06-30+123→ 22,644 total
  • Award
    Sensei Biotherapeutics, Inc.$SNSE

    Common Stock

    2022-06-10+4,466→ 4,466 total
  • Award
    Sensei Biotherapeutics, Inc.$SNSE

    Stock Option (Right to Buy)

    2022-06-10+14,550→ 14,550 total
  • Sale
    Ovintiv Inc.$OVV

    Common Stock

    2022-06-07$59.50/sh−19,231→ 116,269 total
  • Sale
    Ovintiv Inc.$OVV

    Common Stock

    2022-05-23$50.00/sh−10,000→ 135,500 total
  • Exercise/Conversion
    Ovintiv Inc.$OVV

    Restricted Share Unit

    2022-05-18−4,499→ 22,521 total
  • Award
    Ovintiv Inc.$OVV

    Restricted Share Unit

    2022-05-18+4,499→ 27,020 total
  • Exercise/Conversion
    Ovintiv Inc.$OVV

    Common Stock

    2022-05-18+4,499→ 61,433 total
  • Sale
    Ovintiv Inc.$OVV

    Common Stock

    2022-04-18$53.73/sh−10,000→ 145,500 total
  • Award
    Ovintiv Inc.$OVV

    Restricted Share Unit

    2022-03-31+82→ 22,521 total
  • Purchase
    Ovintiv Inc.$OVV

    Common Stock

    2022-03-31+19→ 56,934 total
  • Exercise/Conversion
    Ovintiv Inc.$OVV

    Restricted Share Unit

    2022-03-08−5,184→ 22,438 total
  • Exercise/Conversion
    Ovintiv Inc.$OVV

    Common Stock

    2022-03-08+5,184→ 56,915 total
  • Purchase
    Sensei Biotherapeutics, Inc.$SNSE

    Common Stock

    2021-12-10$5.86/sh+20,000→ 341,769 total
  • Purchase
    Sensei Biotherapeutics, Inc.$SNSE

    Common Stock

    2021-12-09$6.62/sh+20,000→ 321,769 total
  • Award
    Ovintiv Inc.$OVV

    Rights (Director Restricted Stock Unit)

    2021-02-26+7,892→ 27,204 total
  • Conversion
    Sensei Biotherapeutics, Inc.$SNSE

    Series BB Preferred Convertible Stock

    2021-02-08−3,037,849→ 0 total
  • Conversion
    Sensei Biotherapeutics, Inc.$SNSE

    Common Stock

    2021-02-08+301,769→ 301,769 total
  • Conversion
    Sensei Biotherapeutics, Inc.$SNSE

    Series AA Preferred Convertible Stock

    2021-02-08−11,447,156→ 0 total
  • Award
    Sensei Biotherapeutics, Inc.$SNSE

    Stock Option (Right to Buy)

    2021-02-03+16,666→ 16,666 total
  • Purchase
    Ovintiv Inc.$OVV

    Common Stock

    2020-03-18$2.15/sh+50,000→ 155,500 total
  • Purchase
    Ovintiv Inc.$OVV

    Common Stock

    2020-03-09$4.05/sh+25,000→ 65,500 total
  • Purchase
    Ovintiv Inc.$OVV

    Common Stock

    2020-03-09$2.55/sh+40,000→ 105,500 total
  • Award
    Ovintiv Inc.$OVV

    Rights (Director Restricted Stock Unit)

    2020-02-28+13,309→ 18,091 total

Companies

4

Recent Filings

12

Address

363 N. SAM HOUSTON PKWY E, SUITE 100

HOUSTON, TX, 77060

View on SEC.gov